R Mierau

Summary

Country: Germany

Publications

  1. ncbi Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
    Rudolf Mierau
    Rheumaklinik Aachen, Aachen, Germany
    Clin Chem Lab Med 44:138-43. 2006
  2. ncbi Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features
    Rudolf Mierau
    Laboratory at Rheumaklinik Aachen, Hauptstrasse 21, Aachen, D 52066, Germany
    Arthritis Res Ther 13:R172. 2011
  3. ncbi [Scleroderma associated autoantibodies - clinical and diagnostic relevance]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:279-84. 2006
  4. ncbi [Laboratory diagnostics for systemic sclerosis]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:206, 208-11. 2007
  5. ncbi Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis
    T Dick
    Rheumaklinik u Rheumaforschungsinstitut, Aachen, Germany
    Ann Rheum Dis 61:121-7. 2002
  6. ncbi Autoantibodies directed to novel components of the PM/Scl complex, the human exosome
    Rick Brouwer
    Department of Biochemistry, University of Nijmegen, NL 6500 HB Nijmegen, The Netherlands
    Arthritis Res 4:134-8. 2002
  7. ncbi Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis
    Michael Mahler
    Institute of Molecular Genetics, University of Heidelberg, Heidelberg, Germany
    Arthritis Rheum 46:1866-72. 2002
  8. ncbi Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders
    Hans Rudolf Ziswiler
    Department of Rheumatology, Clinical Immunology and Allergology, University Hospital, Bern, Switzerland
    Swiss Med Wkly 137:586-90. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
    Rudolf Mierau
    Rheumaklinik Aachen, Aachen, Germany
    Clin Chem Lab Med 44:138-43. 2006
    ..These laboratory parameters are also relevant for prognosis of disease persistence, functional impairment and radiological progression...
  2. ncbi Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features
    Rudolf Mierau
    Laboratory at Rheumaklinik Aachen, Hauptstrasse 21, Aachen, D 52066, Germany
    Arthritis Res Ther 13:R172. 2011
    ..In the present study, we analysed in detail nuclear autoantibodies and their associations in systemic sclerosis (SSc) patients included in the German Network for Systemic Scleroderma Registry...
  3. ncbi [Scleroderma associated autoantibodies - clinical and diagnostic relevance]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066, Aachen, Germany
    Z Rheumatol 65:279-84. 2006
    ..Some, however, are thought to be relevant to the as yet unanswered question of whether autoantibodies are directly involved in SSc pathogenesis...
  4. ncbi [Laboratory diagnostics for systemic sclerosis]
    R Mierau
    Labor an der Rheumaklinik Aachen, Burtscheider Markt 24, 52066 Aachen
    Z Rheumatol 66:206, 208-11. 2007
    ..Numerous additional laboratory parameters are of value for investigating pathogenesis, but have not yet been generally introduced into the routine diagnostics of systemic sclerosis...
  5. ncbi Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis
    T Dick
    Rheumaklinik u Rheumaforschungsinstitut, Aachen, Germany
    Ann Rheum Dis 61:121-7. 2002
    ..Antibodies targeting DNA topoisomerase I (ATA) or centromere proteins (ACA) are associated with clinical subsets of patients with systemic sclerosis (SSc). The occurrence of those autoantibodies is considered to be mutually exclusive...
  6. ncbi Autoantibodies directed to novel components of the PM/Scl complex, the human exosome
    Rick Brouwer
    Department of Biochemistry, University of Nijmegen, NL 6500 HB Nijmegen, The Netherlands
    Arthritis Res 4:134-8. 2002
    ..These results further support the conception that the autoimmune response may initially be directed to PM/Scl-100, whereas intermolecular epitope spreading may have caused the autoantibody response directed to the associated components...
  7. ncbi Development of a CENP-A/CENP-B-specific immune response in a patient with systemic sclerosis
    Michael Mahler
    Institute of Molecular Genetics, University of Heidelberg, Heidelberg, Germany
    Arthritis Rheum 46:1866-72. 2002
    ..Whether the D-penicillamine treatment received by this patient was involved in the triggering of this cascade remains a matter of speculation...
  8. ncbi Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders
    Hans Rudolf Ziswiler
    Department of Rheumatology, Clinical Immunology and Allergology, University Hospital, Bern, Switzerland
    Swiss Med Wkly 137:586-90. 2007
    ..To compare clinical diagnosis with two validated classification criteria for systemic sclerosis (SSc) in a cohort of Swiss patients with SSc and associated disorders...